Capital Performance Advisors LLP
- SEC CIK
- 0001905663
- Latest filing
- Aug 14, 2026
PLX holding history
Protalix BioTherapeutics, Inc. in every 13F filed by Capital Performance Advisors LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PLX overviewAll 13F holders of PLXFull Q2 2026 holdings
- Shares (Q2 2026)
- 25,975
- Value
- $60.5K
- % of portfolio
- <0.1%
- Quarters held
- 17
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 25,975 | $60.5K | <0.1% | −76−0.3% | Reduced | Holders |
| Q1 2026 | 26,051 | $56.5K | <0.1% | +76+0.3% | Added | Holders |
| Q4 2025 | 25,975 | $46.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 25,975 | $57.7K | <0.1% | −10.0% | Reduced | Holders |
| Q2 2025 | 25,976 | $38.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 25,976 | $66.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 25,976 | $48.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 25,976 | $26.5K | <0.1% | −817−3.0% | Reduced | Holders |
| Q2 2024 | 26,793 | $31.3K | <0.1% | +535+2.0% | Added | Holders |
| Q1 2024 | 26,258 | $33.1K | <0.1% | +283+1.1% | Added | Holders |
| Q4 2023 | 25,975 | $46.2K | <0.1% | +10.0% | Added | Holders |
| Q3 2023 | 25,974 | $43.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 25,974 | $51.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 25,974 | $54.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 25,974 | $35.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 25,974 | $27.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 25,974 | $28.0K | <0.1% | +25,974 | New | Holders |